This announcement is a separate document:
アステラス製薬:avacincaptad pegol(ACP) 欧州における販売承認申請に関する最新情報
Astellas Pharma: Update on avacincaptad pegol (ACP) European sales approval application
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.